Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, septiembre 22
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
BrightSpring Health Services Inc
BTSG
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$55.86
-0.92
-1.62%
al cierre: Sep 18, 5:00 PM EST
$55.19
-1.59
-2.79%
Premercado: 8:31 AM EST
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
BrightSpring Health Financials
BrightSpring Health (BTSG) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.40 by 12.5 percent. This is a 104.55 percent increase over earnings of $0.22 per share
Benzinga Newsdesk
PRO
BrightSpring Health Raises FY2026 Sales Guidance from $14.725B-$15.225B to $15.100B-$15.425B vs $15.064B Est
BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion to $15.100 billion-$15.425 billion vs $15.064 billion estimate.
Benzinga Newsdesk
BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results
BrightSpring Health Services (BTSG) reported strong Q1 results with increased full-year guidance. Analysts have raised price targets for stock.
Avi Kapoor
BrightSpring Extends Rally With Solid Q1, Upgraded Fiscal 2026 Forecast
BrightSpring shares rise after Q1 earnings beat, revenue growth and raised FY26 guidance; analysts cite momentum but note valuation premium.
Vandana Singh
Earnings Scheduled For May 1, 2026
Benzinga Insights
PRO
BrightSpring Health Raises FY2026 Sales Guidance from $14.450B-$15.000B to $14.725B-$15.225B vs $14.847B Est
Full Year 2026 Financial GuidanceFor the full year 2026, BrightSpring is increasing Revenue and Adjusted EBITDA guidance, which excludes the Community Living business and the effects of any future closed acquisitions.
Benzinga Newsdesk
Privacy Manager